FTO and polycystic ovary syndrome: These modifications have been demonstrated to improve the proinflammatory cytokines [55], mitigate the OS condition [56, 57], improve body composition [58] and glucometabolic regulation [59], lower visceral adiposity [60], and balance the gene expressions implicated in the pathogenesis of PCOS such as Nrf2 and FTO [61, 62].